Multicenter prospective observational study of teneligliptin, a selective dipeptidyl peptidase-4 inhibitor, in patients with poorly controlled type 2 diabetes
Takamiya Y; Okamura K; Shirai K; Okuda T; Kobayashi K; Urata H
Clin Exp Hypertens., 23 Apr. 2019, 512(1):1 - 6, Refereed